(1 - 14 from 16
)
DGAP-News: Cytos Biotechnology Presents Novel Toll-Like Receptor 9...
www.wallstreet-online.de
study, which was presented by principal investigator Dr. Kai-Michael Beeh, insaf Respiratory Research Institute, was a randomized, placebo-controlled,
DGAP-News: Cytos to raise up to CHF 37 million from international and...
www.wallstreet-online.de
PD Dr. Kai-Michael Beeh from the insaf Respiratory Research Institute, who has been the principal investigator of a positive Phase II study conducted
sorted by relevance / date